{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:20:00Z","timestamp":1789402800914,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ejso.2025.109735","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T19:18:09Z","timestamp":1740770289000},"page":"109735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Neuroendocrine tumors of the gynecological tract: A narrative literature review"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0534-704X","authenticated-orcid":false,"given":"Aleksandar","family":"\u010celebi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1877-6662","authenticated-orcid":false,"given":"Klejda","family":"Harasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6202-8429","authenticated-orcid":false,"given":"Mirjana","family":"Miladinovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6719-8694","authenticated-orcid":false,"given":"Aljo\u0161a","family":"Mandi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tijana","family":"Vasiljevi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5548-4116","authenticated-orcid":false,"given":"Kristina","family":"Drusany Stari\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6535-5310","authenticated-orcid":false,"given":"Vasilije","family":"Radunovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8510-0398","authenticated-orcid":false,"given":"Irina","family":"Tripac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Karolina","family":"Stari\u010d Drusany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejso.2025.109735_bib1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.rcl.2011.02.011","article-title":"Imaging of neuroendocrine tumors","volume":"49","author":"Heller","year":"2011","journal-title":"Radiol Clin"},{"issue":"7","key":"10.1016\/j.ejso.2025.109735_bib2","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/cncr.25652","article-title":"Identification and validation of Notch pathway activating compounds through a novel high-throughput screening method","volume":"117","author":"Pinchot","year":"2011","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2025.109735_bib3","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1186\/s12885-018-4447-x","article-title":"Neuroendocrine carcinoma of the cervix: a systematic review of the literature","volume":"18","author":"Tempfer","year":"2018","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.ejso.2025.109735_bib4","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.3390\/ijms24076853","article-title":"Neuroendocrine neoplasms of the gastrointestinal tract versus neuroendocrine neoplasms of the gynaecological tract-comparison of the risk factors and non-surgical treatment efficacy","volume":"24","author":"Lorenz","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.ejso.2025.109735_bib5","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.rcl.2020.07.008","article-title":"Multimodality imaging of neuroendocrine tumors","volume":"58","author":"Galgano","year":"2020","journal-title":"Radiol Clin"},{"issue":"10","key":"10.1016\/j.ejso.2025.109735_bib6","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2025.109735_bib7","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.rcl.2020.08.002","article-title":"Neuroendocrine tumors: imaging of treatment and follow-up","volume":"58","author":"Migut","year":"2020","journal-title":"Radiol Clin"},{"issue":"12","key":"10.1016\/j.ejso.2025.109735_bib8","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3390\/medicina57121338","article-title":"Emerging therapeutic concepts and latest diagnostic advancements regarding neuroendocrine tumors of the gynecologic tract","volume":"57","author":"Georgescu","year":"2021","journal-title":"Medicina (Kaunas)"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2025.109735_bib9","first-page":"128","article-title":"An update of neuroendocrine tumors of the female reproductive system","volume":"31","author":"Kefeli","year":"2015","journal-title":"Turk Patoloji Derg"},{"issue":"1","key":"10.1016\/j.ejso.2025.109735_bib10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ygyno.2021.04.039","article-title":"Neuroendocrine tumors of the gynecologic tract update","volume":"162","author":"Winer","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2025.109735_bib11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ygyno.2020.05.452","article-title":"Molecular profiling in a large cohort of gynecologic neuroendocrine tumors","volume":"159","author":"Crane","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2025.109735_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11912-017-0617-2","article-title":"Pathology of neuroendocrine tumours of the female genital tract","volume":"19","author":"Howitt","year":"2017","journal-title":"Curr Oncol Rep"},{"issue":"4","key":"10.1016\/j.ejso.2025.109735_bib13","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.3802\/jgo.2019.30.e58","article-title":"Clinical comparison between neuroendocrine and endometrioid type carcinoma of the uterine corpus","volume":"30","author":"Mei","year":"2019","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.109735_bib14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ygyno.2011.04.011","article-title":"Neuroendocrine tumors of the gynecologic tract: a Society of Gynecologic Oncology (SGO) clinical document","volume":"122","author":"Gardner","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.109735_bib15","first-page":"1043","article-title":"Neuroendocrine carcinoma of the endometrium: a retrospective study with clinical and molecular analysis","volume":"23","author":"Zhao","year":"2023","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.ejso.2025.109735_bib16","first-page":"1417","article-title":"Clinical characteristic and prognostic factors in high-grade neuroendocrine cervical carcinoma: a retrospective study of 107 cases","volume":"47","author":"Zhao","year":"2021","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"10.1016\/j.ejso.2025.109735_bib17","first-page":"1043","article-title":"Neuroendocrine carcinoma of the endometrium: a retrospective study with clinical and molecular analysis","volume":"23","author":"Zhao","year":"2023","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2025.109735_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s13244-014-0378-5","article-title":"Neuroendocrine tumours of the female genital tract: a case-based imaging review with pathological correlation","volume":"6","author":"Lopes Dias","year":"2015","journal-title":"Insights Imaging"},{"issue":"7","key":"10.1016\/j.ejso.2025.109735_bib19","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3390\/cancers14071835","article-title":"Neuroendocrine neoplasms of the gynecologic tract","volume":"14","author":"Virarkar","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2025.109735_bib20","article-title":"Neuroendocrine cervical cancer: have we made any steps forward in its management?","volume":"30","author":"Mandic","year":"2024","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2025.109735_bib21","article-title":"Advances in research, diagnosis, and treatment of neuroendocrine cervical carcinoma: a review","volume":"17","author":"Ren","year":"2023","journal-title":"Onco Rev"},{"key":"10.1016\/j.ejso.2025.109735_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.916506","article-title":"Small cell (neuroendocrine) carcinoma of the cervix: an analysis for 19 cases and literature review","volume":"12","author":"Lu","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ejso.2025.109735_bib23","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ygyno.2017.12.001","article-title":"A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix","volume":"148","author":"Castle","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2025.109735_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ygyno.2016.02.008","article-title":"Natural history and outcome of neuroendocrine carcinoma of the cervix","volume":"141","author":"Margolis","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"14","key":"10.1016\/j.ejso.2025.109735_bib25","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1002\/cam4.4034","article-title":"PD-L1, PARP1, and MMRs as potential therapeutic biomarkers for neuroendocrine cervical cancer","volume":"10","author":"Ji","year":"2021","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.ejso.2025.109735_bib26","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/PAS.0000000000001042","article-title":"Next-generation sequencing reveals recurrent somatic mutations in small cell neuroendocrine carcinoma of the uterine cervix","volume":"42","author":"Xing","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.ejso.2025.109735_bib27","doi-asserted-by":"crossref","first-page":"8095","DOI":"10.18632\/oncotarget.14098","article-title":"Cervical small cell neuroendocrine tumor mutation profiles via whole exome sequencing","volume":"8","author":"Cho","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejso.2025.109735_bib28","article-title":"Prognostic factors and treatment of neuroendocrine tumors of the uterine cervix based on the FIGO 2018 staging system: a single-institution study of 172 patients","volume":"9","author":"Chen","year":"2021","journal-title":"PeerJ"},{"key":"10.1016\/j.ejso.2025.109735_bib29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.gore.2014.09.003","article-title":"Response to MEK inhibitor in small cell neuroendocrine carcinoma of the cervix with a KRAS mutation","volume":"10","author":"Lyons","year":"2014","journal-title":"Gynecol. Oncol. Rep"},{"key":"10.1016\/j.ejso.2025.109735_bib30","first-page":"271","article-title":"Carcinoids of the ovary: an analysis of 329 reported cases","volume":"19","author":"Soga","year":"2000","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ejso.2025.109735_bib31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.22543\/7674.81.P4452","article-title":"A mini-review regarding the carcinogenesis and morphology of serous tumors of the ovary, fallopian tube and peritoneum","volume":"8","author":"Georgescu","year":"2021","journal-title":"J. Mind Med. Sci."},{"issue":"10","key":"10.1016\/j.ejso.2025.109735_bib32","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/00000478-199210000-00002","article-title":"Primary ovarian small cell carcinoma of pulmonary type. A clinicopathologic, immunohistologic, and flow cytometric analysis of 11 cases","volume":"16","author":"Eichhorn","year":"1992","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 2","key":"10.1016\/j.ejso.2025.109735_bib33","doi-asserted-by":"crossref","first-page":"S623","DOI":"10.4103\/jcrt.jcrt_28_22","article-title":"Primary neuroendocrine tumors of ovary: a clinicopathological spectrum in a tertiary care hospital with review of literature","volume":"19","author":"Kushwaha","year":"2023","journal-title":"J Cancer Res Therapeut"},{"issue":"1","key":"10.1016\/j.ejso.2025.109735_bib34","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ygyno.2011.04.011","article-title":"Neuroendocrine tumors of the gynecologic tract: a Society of Gynecologic Oncology (SGO) clinical document","volume":"122","author":"Gardner","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2025.109735_bib35","first-page":"1","article-title":"Large cell neuroendocrine carcinoma (LCNEC) of the ovary: a case report and review of the literature","volume":"3","author":"Jang","year":"2016","journal-title":"Integr. Cancer Sci. Ther."},{"issue":"2","key":"10.1016\/j.ejso.2025.109735_bib36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0090-8258(89)80032-0","article-title":"Neuron-specific enolase as a serum marker for immature teratoma and dysgerminoma","volume":"32","author":"Kawata","year":"1989","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2025.109735_bib37","doi-asserted-by":"crossref","first-page":"855","DOI":"10.4103\/ijpm.ijpm_954_21","article-title":"Neuroendocrine carcinoma of ovary: hitherto rare entity in primary ovarian tumors","volume":"66","author":"Osama","year":"2023","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.ejso.2025.109735_bib38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.7150\/jca.26978","article-title":"An in-depth look at small cell carcinoma of the ovary, hypercalcemic type (SCCOHT): clinical implications from recent molecular findings","volume":"10","author":"Lu","year":"2019","journal-title":"J Cancer"},{"key":"10.1016\/j.ejso.2025.109735_bib39","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1158\/1078-0432.CCR-19-3797","article-title":"Small-cell carcinoma of the ovary, hypercalcemic type-genetics, new treatment targets, and current management guidelines","volume":"26","author":"Tischkowitz","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.ejso.2025.109735_bib40","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13048-016-0259-2","article-title":"Genomic alterations in neuroendocrine cancers of the ovary","volume":"9","author":"Yaghmour","year":"2016","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.ejso.2025.109735_bib41","article-title":"Primary neuroendocrine tumors of the endometrium: management and outcomes","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2025.109735_bib42","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.3802\/jgo.2019.30.e103","article-title":"Clinicopathologic features, treatment, prognosis and prognostic factors of neuroendocrine carcinoma of the endometrium: a retrospective analysis of 42 cases from the kansai clinical Oncology group\/intergroup study in Japan","volume":"30","author":"Matsumoto","year":"2019","journal-title":"J Gynecol Oncol"},{"issue":"23","key":"10.1016\/j.ejso.2025.109735_bib43","doi-asserted-by":"crossref","first-page":"8558","DOI":"10.1002\/cam4.4368","article-title":"Primary neuroendocrine tumors of the ovary: management and outcomes","volume":"10","author":"Pang","year":"2021","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.ejso.2025.109735_bib44","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/PAP.0b013e318234ab18","article-title":"Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features","volume":"18","author":"Bartosch","year":"2011","journal-title":"Adv Anat Pathol"},{"issue":"5","key":"10.1016\/j.ejso.2025.109735_bib45","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/PAS.0000000000000633","article-title":"Neuroendocrine carcinoma of the endometrium: a clinicopathologic study of 25 cases","volume":"40","author":"Pocrnich","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.ejso.2025.109735_bib46","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.annonc.2022.05.519","article-title":"Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study","volume":"33","author":"Maio","year":"2022","journal-title":"Ann Oncol"},{"issue":"6349","key":"10.1016\/j.ejso.2025.109735_bib47","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.ejso.2025.109735_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-234977","article-title":"Primary mixed large cell neuroendocrine and high grade serous carcinoma of the endometrium","volume":"13","author":"Hardy","year":"2020","journal-title":"BMJ Case Rep"},{"issue":"5","key":"10.1016\/j.ejso.2025.109735_bib49","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1136\/ijgc-00009577-200409000-00041","article-title":"Small cell carcinoma of the endometrium: report of three cases and literature review","volume":"14","author":"Katahira","year":"2004","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2025.109735_bib50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00004347-198403010-00005","article-title":"Argyrophilia, serotonin, and peptide hormones in the female genital tract and its tumors","volume":"3","author":"Scully","year":"1984","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ejso.2025.109735_bib51","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.2147\/CMAR.S314686","article-title":"Retrospective analysis of clinicopathological features and prognosis of gynecological small-cell carcinoma","volume":"13","author":"Pang","year":"2021","journal-title":"Cancer Manag Res"},{"issue":"8","key":"10.1016\/j.ejso.2025.109735_bib52","doi-asserted-by":"crossref","first-page":"857","DOI":"10.5858\/2004-128-857-PSCNCO","article-title":"Primary small cell neuroendocrine carcinoma of the vagina: a clinicopathologic study","volume":"128","author":"Bing","year":"2004","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.ejso.2025.109735_bib53","first-page":"784","article-title":"Small cell neuroendocrine carcinoma of the vagina Cancer","volume":"70","author":"Joseph","year":"1992"},{"key":"10.1016\/j.ejso.2025.109735_bib54","first-page":"717","article-title":"Merkel cell carcinoma of the vulva Saudi","volume":"30","author":"Mohit","year":"2009","journal-title":"Med J"},{"issue":"5","key":"10.1016\/j.ejso.2025.109735_bib55","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1365-2133.2011.10451.x","article-title":"Primary cutaneous small cell carcinoma of the vulva arising from squamous cell carcinoma","volume":"165","author":"Matsumoto","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejso.2025.109735_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104201","article-title":"Primary neuroendocrine neoplasms of the vulva: a review of the MITO rare cancer group","volume":"193","author":"Barcellini","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"10.1016\/j.ejso.2025.109735_bib57","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ygyno.2020.05.682","article-title":"Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract","volume":"158","author":"Frumovitz","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"17","key":"10.1016\/j.ejso.2025.109735_bib58","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1016\/j.ejca.2007.08.031","article-title":"Cancer testis antigen expression in primary and recurrent vulvar cancer: association with prognostic factors","volume":"43","author":"Bellati","year":"2007","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.ejso.2025.109735_bib59","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/jog.14237","article-title":"Rare case of tonsillar and subcutaneous metastasis from neuroendocrine cervical cancer","volume":"46","author":"Zeng","year":"2020","journal-title":"J Obstet Gynaecol Res"},{"issue":"5","key":"10.1016\/j.ejso.2025.109735_bib60","first-page":"114","article-title":"Small cell neuroendocrine carcinoma of the endometrium with pulmonary metastasis: a clinicopathologic study of a case and a brief review of the literature","author":"D'Antonio","year":"2015","journal-title":"Surgery (Oxf)"},{"issue":"1","key":"10.1016\/j.ejso.2025.109735_bib61","article-title":"Prognostic model for survival in patients with neuroendocrine carcinomas of the cervix: SEER database analysis and a single-center retrospective study","volume":"19","author":"Yu","year":"2024","journal-title":"PLoS"},{"issue":"3","key":"10.1016\/j.ejso.2025.109735_bib62","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ygyno.2021.04.019","article-title":"The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervix","volume":"161","author":"Pei","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2025.109735_bib63","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5468\/ogs.2016.59.2.116","article-title":"Prognostic factors in neuroendocrine cervical carcinoma","volume":"59","author":"Lee","year":"2016","journal-title":"Obstet Gynecol Sci"},{"issue":"10","key":"10.1016\/j.ejso.2025.109735_bib64","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.3390\/curroncol29100587","article-title":"Neuroendocrine carcinomas of the uterine cervix, endometrium, and ovary show higher tendencies for bone, brain, and liver organotrophic metastases","volume":"29","author":"Park","year":"2022","journal-title":"Curr Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325001635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325001635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:12:06Z","timestamp":1774858326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325001635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0748798325001635"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.109735","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroendocrine tumors of the gynecological tract: A narrative literature review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.109735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109735"}}